Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorAZUARA-BLANCO, Augusto
dc.contributor.authorMCCORRY, Noleen
dc.contributor.authorTATHAM, Andrew J
dc.contributor.authorGEORGOULAS, Stelios
dc.contributor.authorFOUNTI, Panayiota
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorSCHWEITZER, Cedric
ORCID: 0000-0002-2162-9479
IDREF: 133631583
dc.contributor.authorMEIER-GIBBONS, Frances
dc.contributor.authorDENIS, Philippe
dc.contributor.authorTUULONEN, Anja
dc.contributor.authorJOHANNESSON, Gauti
dc.contributor.authorMARTINEZ DE LA CASA, Jose Maria
dc.contributor.authorPROKOSCH, Verena
dc.contributor.authorGIANNOULIS, Dimitrios A
dc.contributor.authorABEGAO PINTO, Luis
dc.contributor.authorGARWAY-HEATH, David
dc.contributor.authorTOPOUZIS, Fotis
dc.date.accessioned2024-01-09T14:03:34Z
dc.date.available2024-01-09T14:03:34Z
dc.date.issued2023-11-03
dc.identifier.issn1468-2079en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/186977
dc.description.abstractEnBACKGROUND/AIMS: The goal of health research is to improve patients care and outcomes. Thus, it is essential that research addresses questions that are important to patients and clinicians. The aim of this study was to develop a list of priorities for glaucoma research involving stakeholders from different countries in Europe. METHODS: We used a three-phase method, including a two-round electronic Delphi survey and a workshop. The clinician and patient electronic surveys were conducted in parallel and independently. For phase I, the survey was distributed to patients from 27 European countries in 6 different languages, and to European Glaucoma Society members, ophthalmologists with expertise in glaucoma care, asking to name up to five research priorities. During phase II, participants were asked to rank the questions identified in phase I using a Likert scale. Phase III was a 1 day workshop with patients and clinicians. The purpose was to make decisions about the 10 most important research priorities using the top 20 priorities identified by patients and clinicians. RESULTS: In phase I, 308 patients and 150 clinicians were involved. In phase II, the highest-ranking priority for both patients and clinicians was 'treatments to restore vision'. In phase III, eight patients and four clinicians were involved. The top three priorities were 'treatments to stop sight loss', 'treatments to restore vision' and 'improved detection of worsening glaucoma'. CONCLUSION: We have developed a list of priorities for glaucoma research involving clinicians and patients from different European countries that will help guide research efforts and investment.
dc.language.isoENen_US
dc.rightsAttribution-NonCommercial 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/us/*
dc.title.enEuropean Glaucoma Society research priorities for glaucoma care
dc.title.alternativeBr J Ophthalmolen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1136/bjo-2023-323648en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed37923373en_US
bordeaux.journalBritish Journal of Ophthalmologyen_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamLEHA_BPHen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-04382690
hal.version1
hal.date.transferred2024-01-09T14:03:39Z
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exporttrue
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=British%20Journal%20of%20Ophthalmology&rft.date=2023-11-03&rft.eissn=1468-2079&rft.issn=1468-2079&rft.au=AZUARA-BLANCO,%20Augusto&MCCORRY,%20Noleen&TATHAM,%20Andrew%20J&GEORGOULAS,%20Stelios&FOUNTI,%20Panayiota&rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée